VMI
AXSM icon

VHCP Management II’s Axsome Therapeutics AXSM Stock Holding History

VHCP Management II’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$81.2M Sell
785,981
-106,965
-12% -$4.32M 21.42% 2
2019
Q3 		$18.1M Hold
892,946
– – 6.89% 6
2019
Q2 		$23M Buy
892,946
+320,990
+56% +$6.43M 7.25% 5
2019
Q1 		$8.14M Buy
+571,956
New +$5.31M 2.38% 12

Other funds holding AXSM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VHCP Management II's AXSM Position: Q4 2019 in Review

VHCP Management II reduced its Axsome Therapeutics (AXSM) stake by 12% in Q4 2019, selling an estimated $4.32M and leaving 785,981 shares worth $81.2M. The position accounts for 21.42% of the portfolio, ranked #2.

VHCP Management II first reported a position in AXSM in Q1 2019 and has held it in 4 quarters since. 169 funds tracked by Wall St. Rank hold AXSM as of Q4 2019.

  • VHCP Management II held 785,981 shares of Axsome Therapeutics worth $81.2M as of Q4 2019.
  • VHCP Management II sold 106,965 Axsome Therapeutics shares in Q4 2019, an estimated $4.32M.
  • Axsome Therapeutics made up 21.42% of VHCP Management II's portfolio in Q4 2019, its #2 holding.
  • VHCP Management II first reported a position in Axsome Therapeutics in Q1 2019 and has held it in 4 quarters since.
  • 169 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.